Dermata Therapeutics, Inc.Dermata Therapeutics, Inc.Dermata Therapeutics, Inc.

Dermata Therapeutics, Inc.

No trades
See on Supercharts

Price target

6.000.000.00%
The 1 analyst offering 1 year price forecasts for DRMA have a max estimate of — and a min estimate of —.

Analyst rating

Based on 1 analyst giving stock ratings to DRMA in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


DRMA EPS for the last quarter is −2.04 USD despite the estimation of −2.64 USD. In the next quarter EPS is expected to reach −1.36 USD. Track more of Dermata Therapeutics, Inc. financials and stay on top of what is up with the company.
According to analysts, DRMA price target is 6.00 USD with a max estimate of 6.00 USD and a min estimate of 6.00 USD. Check if this forecast comes true in a year, meanwhile watch Dermata Therapeutics, Inc. stock price chart and keep track of the current situation with DRMA news and stock market news.